News Results
There are 914,359 News Results
Oct 15, 2018
SAN DIEGO and PENNINGTON, N.J., Oct. 15, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has initiated KEYNOTE-890, a Phase...
Oct 17, 2018
DUBLIN, Oct. 17, 2018 /PRNewswire/ -- The "Language Translation Software and Services - Global Strategic Business Report" report has been added to
Oct 26, 2018
ADELAIDE, Australia, Oct. 26, 2018 /PRNewswire/ -- -- Mayne Pharma Group Limited ("Mayne Pharma") (ASX: MYX) has acquired the FDA approved halobetasol propionate foam 0.05% for an investment of up...
Oct 31, 2018
CHARLOTTE, N.C., Oct. 31, 2018 /PRNewswire/ -- LendingTree® , the nation's leading online loan marketplace, today released its study on how buying a house affects credit scores. The analysis looked...
Nov 1, 2018
UQM Technologies, Inc. (NYSE American: UQM) (“UQM” or the “Company”), a developer of alternative energy technologies, today announced operating results for the third quarter ended September 30, 2018. Third Quarter...
Nov 1, 2018
SOUTH SAN FRANCISCO, Calif., Nov. 1, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that two-year safety and efficacy data from its FIT Phase 3 extension study (FIT3)...
Nov 2, 2018
CHICAGO, Nov. 2, 2018 /PRNewswire/ -- CME Group , the world's leading and most diverse derivatives marketplace, reached average daily volume (ADV) of 20.6 million contracts per day during October...
Nov 8, 2018
CLEVELAND, Nov. 8, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) ("the Company") today announced financial results for the third quarter ended September 30, 2018.
Nov 12, 2018
Mace Security International, Inc. (OTCQX: MACE) today released unaudited financial results for the quarter ended September 30, 2018. The Company is pleased to announce another quarter of increased revenues with...
Nov 16, 2018
PALO ALTO, Calif., Nov. 16, 2018 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today reported...
